Soligenix Inc. (SNGX)

Soligenix Inc. (SNGX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $7.4M; returns 1 day +0.1%, 1 week +3.4%, 1 year -77.2%.

Soligenix Inc is a late-stage biopharmaceutical company focused on developing and commercializing products for rare diseases and public health threats. It operates via two primary segments: Specialized BioTherapeutics and Public Health Solutions.

Groups SNGX belongs to

• Biotechnology
• Biopharmaceutical
• Healthcare
• Clinical Stage Biotech
• Rare Diseases
• Life Sciences
• Oncology
• Public Sector
• National Security

SNGX financial model: income statement, cash flow and balance sheet